What does agenus inc. — financial royalty assets, net mean?

This represents the current book value of royalty assets related to Agenus Inc. after accounting for all applicable allowances and valuation adjustments. It provides a net carrying amount that reflects the expected recoverable value of the future royalty streams from these specific drug assets. Investors use this figure to assess the tangible value remaining on the balance sheet from this specific partnership segment.

Ligand Pharmaceuticals LGND Agenus Inc. — Financial Royalty Assets, Net

Similar metrics at other companies

TPLRoyalty interests acquired, net

$831.45M+94.0%

RPRXIncome from financial royalty assets — Total income and other revenues

$594.99M+10.3%

RGLDRoyalty interest — Stream and royalty interests, net (Note 3)

$4.06B—

BBIODeferred royalty obligations, net

$871.19M+75.2%

VTRSGenerics — Finite-lived intangible assets, net

$1.29B-18.0%

UTHRAdcirca — Royalty as a percentage of net sales

2.5%0.0pp

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.51B+96.7%

Enterprise value$5.4B+95.4%

P/E35.9×—

P/S20.1×+4.6×

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept lgnd:FinancialRoyaltyAssetsNet.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's agenus inc. — financial royalty assets, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's agenus inc. — financial royalty assets, net?: Ligand Pharmaceuticals (LGND) reported agenus inc. — financial royalty assets, net of $40.41M in Q1 2026.
What does agenus inc. — financial royalty assets, net mean?: This represents the current book value of royalty assets related to Agenus Inc. after accounting for all applicable allowances and valuation adjustments. It provides a net carrying amount that reflects the expected recoverable value of the future royalty streams from these specific drug assets. Investors use this figure to assess the tangible value remaining on the balance sheet from this specific partnership segment.